Skip to content
10-Q

Quarterly Report

BRILLIANT N.E.V. CORP.

0001520138-26-000145

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Apr 30, 2026 153.11M sh
Cash And Equivalents Q3 2025 · Apr 30, 2025 $6.35K
Cash And Equivalents Q3 2025 · Jul 31, 2024 $7.97K
Current Liabilities Q3 2025 · Apr 30, 2025 $49.15K
Current Liabilities Q3 2025 · Jul 31, 2024 $49.24K
Total Liabilities Q3 2025 · Apr 30, 2025 $49.15K
Total Liabilities Q3 2025 · Jul 31, 2024 $49.24K
Current Assets Q3 2025 · Apr 30, 2025 $6.35K
Current Assets Q3 2025 · Jul 31, 2024 $7.97K
Total Assets Q3 2025 · Apr 30, 2025 $6.35K
Total Assets Q3 2025 · Jul 31, 2024 $7.97K
Shares Diluted Q3 2025 · Apr 30, 2024 153.11M sh
Shares Diluted Q3 2025 · Apr 30, 2024 153.11M sh
Stockholders Equity Q3 2025 · Apr 30, 2024 −$41.42K
Stockholders Equity Q3 2025 · Jan 31, 2024 −$31.64K
Stockholders Equity Q3 2025 · Oct 31, 2023 −$18.62K
Stockholders Equity Q3 2025 · Jul 31, 2023 −$5.4K
Sga Expense restated Q3 2025 · Apr 30, 2024 $2.02K
Net Income restated Q3 2025 · Apr 30, 2024 −$13.02K
Net Income Q3 2025 · Apr 30, 2024 −$36.02K
Operating Income restated Q3 2025 · Apr 30, 2024 −$13.02K
Operating Income Q3 2025 · Apr 30, 2024 −$36.02K